Norris ORIEN Total Cancer Care
Launched by UNIVERSITY OF SOUTHERN CALIFORNIA · Nov 17, 2016
Trial Information
Current as of September 01, 2025
Recruiting
Keywords
ClinConnect Summary
The Norris ORIEN Total Cancer Care trial is a research study aimed at understanding cancer better. It collects biological samples (like blood or tissue) and medical information from patients who have cancer or are at risk of developing cancer. By combining this genetic information with clinical data, the study hopes to discover why some cancers respond better to certain treatments. This knowledge could help create more personalized treatment plans for patients in the future.
To participate in this trial, you need to be a patient at the University of Southern California (USC) Norris, and you must be able to understand and sign the necessary consent forms, which are available in both English and Spanish. If you meet these criteria and decide to join, you’ll be contributing to important research that could help improve cancer treatment for many people. The study is currently recruiting participants of all genders aged 65 to 74.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Limited to those patients who are registered for outpatient or inpatient care at University of Southern California (USC) Norris
- • Able to understand and sign the TCCP informed consent, California subject's bill of rights, Health Insurance Portability and Accountability Act (HIPAA), and research authorization form directly or through an authorized representative; the informed consent, subject's bill of rights, HIPAA, and research authorization will be available in both English and Spanish languages
- Exclusion Criteria:
- • Individuals who are not registered as patients for outpatient or inpatient care at USC Norris
- • Individuals who are unable to understand or sign the TCCP informed consent, subject's bill of rights, HIPAA, and research authorization in either English or Spanish
About University Of Southern California
The University of Southern California (USC) is a prestigious research institution located in Los Angeles, California, known for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USC leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct cutting-edge research aimed at improving patient outcomes and public health. The university fosters collaboration among its diverse faculty and students, ensuring a dynamic environment for the development and implementation of clinical studies that adhere to the highest ethical and scientific standards. Through its clinical trials, USC aims to contribute to the advancement of medical science and the translation of research findings into practical applications that benefit communities locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Trial Officials
Bodour Salhia, PhD
Principal Investigator
University of Southern California
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials